Guide

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Guide Correlate

Bonus edilizi 2026: novità Ecobonus, Sismabonus e Bonus Mobili

Ecobonus e ristrutturazioni 2026: aliquote confermate e riduzioni rinviate Per l’Ecobonus e le detrazioni sulle ristrutturazioni la Legge di Bilancio 2026 posticipa le riduzioni delle aliquote al 2027: 50% per interventi sull’abitazione principale, per spese sostenute nel 2025 e 2026, 36% per altri interventi, dal 2028 si applicherà un’aliquota unica

Leggi la guida

Manovra di Bilancio 2026: Novità Fiscali per Partite IVA e Imprese

Regime forfettario 2026: conferma dei limiti Per il 2026 resta confermato il limite di 35.000 euro di reddito da lavoro dipendente percepito nell’anno precedente per poter accedere o permanere nel regime forfettario.  Questa misura garantisce continuità ai titolari di Partita IVA che rispettano i requisiti di reddito, permettendo di mantenere

Leggi la guida